162 related articles for article (PubMed ID: 27626101)
1. A Small-Molecule Screening Platform for the Discovery of Inhibitors of Undecaprenyl Diphosphate Synthase.
Czarny TL; Brown ED
ACS Infect Dis; 2016 Jul; 2(7):489-99. PubMed ID: 27626101
[TBL] [Abstract][Full Text] [Related]
2. Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase.
Farha MA; Czarny TL; Myers CL; Worrall LJ; French S; Conrady DG; Wang Y; Oldfield E; Strynadka NC; Brown ED
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):11048-53. PubMed ID: 26283394
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate Synthase.
Concha N; Huang J; Bai X; Benowitz A; Brady P; Grady LC; Kryn LH; Holmes D; Ingraham K; Jin Q; Pothier Kaushansky L; McCloskey L; Messer JA; O'Keefe H; Patel A; Satz AL; Sinnamon RH; Schneck J; Skinner SR; Summerfield J; Taylor A; Taylor JD; Evindar G; Stavenger RA
J Med Chem; 2016 Aug; 59(15):7299-304. PubMed ID: 27379833
[TBL] [Abstract][Full Text] [Related]
4. Bacterial Cell Growth Inhibitors Targeting Undecaprenyl Diphosphate Synthase and Undecaprenyl Diphosphate Phosphatase.
Wang Y; Desai J; Zhang Y; Malwal SR; Shin CJ; Feng X; Sun H; Liu G; Guo RT; Oldfield E
ChemMedChem; 2016 Oct; 11(20):2311-2319. PubMed ID: 27578312
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Development of Undecaprenyl Pyrophosphate Synthase Inhibitors as Potential Antibacterials.
Jukic M; Rozman K; Gobec S
Curr Med Chem; 2016; 23(5):464-82. PubMed ID: 26718796
[TBL] [Abstract][Full Text] [Related]
6. Structural Insights into the Inhibition of Undecaprenyl Pyrophosphate Synthase from Gram-Positive Bacteria.
Workman SD; Day J; Farha MA; El Zahed SS; Bon C; Brown ED; Organ MG; Strynadka NCJ
J Med Chem; 2021 Sep; 64(18):13540-13550. PubMed ID: 34473495
[TBL] [Abstract][Full Text] [Related]
7. Undecaprenyl diphosphate synthase inhibitors: antibacterial drug leads.
Sinko W; Wang Y; Zhu W; Zhang Y; Feixas F; Cox CL; Mitchell DA; Oldfield E; McCammon JA
J Med Chem; 2014 Jul; 57(13):5693-701. PubMed ID: 24827744
[TBL] [Abstract][Full Text] [Related]
8. A Defective Undecaprenyl Pyrophosphate Synthase Induces Growth and Morphological Defects That Are Suppressed by Mutations in the Isoprenoid Pathway of Escherichia coli.
MacCain WJ; Kannan S; Jameel DZ; Troutman JM; Young KD
J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986944
[TBL] [Abstract][Full Text] [Related]
9. The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitors.
Li H; Huang J; Jiang X; Seefeld M; McQueney M; Macarron R
J Biomol Screen; 2003 Dec; 8(6):712-5. PubMed ID: 14711397
[TBL] [Abstract][Full Text] [Related]
10. Undecaprenyl diphosphate synthase, a cis-prenyltransferase synthesizing lipid carrier for bacterial cell wall biosynthesis.
Teng KH; Liang PH
Mol Membr Biol; 2012 Nov; 29(7):267-73. PubMed ID: 22471620
[TBL] [Abstract][Full Text] [Related]
11. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
Gautam A; Rishi P; Tewari R
Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial drug leads: DNA and enzyme multitargeting.
Zhu W; Wang Y; Li K; Gao J; Huang CH; Chen CC; Ko TP; Zhang Y; Guo RT; Oldfield E
J Med Chem; 2015 Feb; 58(3):1215-27. PubMed ID: 25574764
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.
Danley DE; Baima ET; Mansour M; Fennell KF; Chrunyk BA; Mueller JP; Liu S; Qiu X
Protein Sci; 2015 Jan; 24(1):20-6. PubMed ID: 25287857
[TBL] [Abstract][Full Text] [Related]
14. Species differences in alternative substrate utilization by the antibacterial target undecaprenyl pyrophosphate synthase.
Dodbele S; Martinez CD; Troutman JM
Biochemistry; 2014 Aug; 53(30):5042-50. PubMed ID: 25020247
[TBL] [Abstract][Full Text] [Related]
15. Anti-infectious agents against MRSA.
Koyama N; Inokoshi J; Tomoda H
Molecules; 2012 Dec; 18(1):204-24. PubMed ID: 23262449
[TBL] [Abstract][Full Text] [Related]
16. A synthetic lethal approach for compound and target identification in Staphylococcus aureus.
Pasquina L; Santa Maria JP; McKay Wood B; Moussa SH; Matano LM; Santiago M; Martin SE; Lee W; Meredith TC; Walker S
Nat Chem Biol; 2016 Jan; 12(1):40-5. PubMed ID: 26619249
[TBL] [Abstract][Full Text] [Related]
17. Isoprenoid Biosynthesis Inhibitors Targeting Bacterial Cell Growth.
Desai J; Wang Y; Wang K; Malwal SR; Oldfield E
ChemMedChem; 2016 Oct; 11(19):2205-2215. PubMed ID: 27571880
[TBL] [Abstract][Full Text] [Related]
18. Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones.
Peukert S; Sun Y; Zhang R; Hurley B; Sabio M; Shen X; Gray C; Dzink-Fox J; Tao J; Cebula R; Wattanasin S
Bioorg Med Chem Lett; 2008 Mar; 18(6):1840-4. PubMed ID: 18295483
[TBL] [Abstract][Full Text] [Related]
19. Structures, mechanisms and inhibitors of undecaprenyl diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesis.
Teng KH; Liang PH
Bioorg Chem; 2012 Aug; 43():51-7. PubMed ID: 21993493
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
